Where Global Innovation
and Capital Meet
LIVE

Flotation

Exits: November 26, 2021

A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

Nov 26, 2021

Blade to get a slice of Nasdaq action

Johns Hopkins spinout Blade Therapeutics has agreed to a reverse merger that will net it $24.3m in Pipe financing from backers including Osage University Partners.

Nov 11, 2021

Entrada Therapeutics enters Nasdaq

The Ohio State spinout has gone public in an upsized IPO sized at approximately $182m.

Nov 11, 2021

Pyxis progresses to stock market

Having priced its shares at the top of its range, UChicago spinout Pyxis Oncology suffered a drop on the first day of trading.

Oct 11, 2021

Exscientia expands IPO to over $350m

The cancer drug developer has closed its initial public offering after underwriters exercised the greenshoe option.

Oct 7, 2021

Pyxis picks price range

UChicago spinout Pyxis Oncology is aiming to raise more than $153m in its initial public offering, having set a price range of $14 to $16.

Oct 5, 2021

Exscientia establishes Nasdaq listing

The Dundee spinout has raised more than $304m in its IPO in the US, with another $160m secured through a concurrent private placement.

Oct 4, 2021

Other News

Li-S Energy celebrates market debut

Based on research at Deakin University, Li-S Energy has gone public on the Australian Stock Exchange after raising $25m in its initial public offering.

Sep 30, 2021

Lucid Diagnostics lines up IPO

Case Western Reserve University-linked Lucid Diagnostics is seeking an initial public offering that would net it up to $57.5m.

Sep 28, 2021

Oxford Nanopore sets IPO plans in motion

Oracle has signed up to be a cornerstone investor for Oxford Nanopore’s initial public offering, putting up half of the $410m target.

Sep 21, 2021

Prenetics tests out $1.25bn reverse merger

Genetic testing services provider Prenetics, a spinout of City University of Hong Kong, will hold a reverse merger at a $1.25bn valuation.

Sep 17, 2021

Context Therapeutics frames IPO plans

Based on research at Drexel University, Context Therapeutics is seeking to raise up to $21m in an initial public offering on Nasdaq.

Sep 15, 2021

Exscientia explores Nasdaq IPO

Dundee spinout Exscientia is continuing a busy fundraising year with a filing for an IPO in the US and a $35m concurrent private placement.

Sep 13, 2021

Editor's Picks

Braze breaches public markets in $520m IPO

Citi Ventures-backed Braze priced the offering above its range and it valued the customer engagement software producer at almost $5.9bn.

Nov 18, 2021

Paytm puts together $2.5bn IPO

The Alibaba, Ant Group, Berkshire Hathaway, Intel and SoftBank-backed e-commerce payment app operator is set to list on the NSE and BSE next week at a potential valuation of up to $18.7bn.

Nov 12, 2021

Rivian motors to $11.9bn IPO

Amazon, Ford, Cox Enterprises, Abdul Latif Jameel and Sumitomo are all notching up exits, as the electric jeep producer priced the largest initial public offering of 2021.

Nov 10, 2021

Rent the Runway lands $357m in IPO

Advance Publications and American Express scored exits as the fashion subscription service floated at the top of its range in an upsized offering.

Oct 29, 2021
© 2021 Mawsonia Ltd. All rights reserved.
test reg

Login